Disc Medicine

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$0
$0
Gross Profit
-20
-9
-11
EBITDA
-54,200
-33,049
-13,251
-32,845
EBIT
-54,285
-33,069
-13,260
-32,856
Net Income
-55,247
-34,085
-29,457
-26,599
Net Change In Cash
0
0
0
0
Free Cash Flow
-47,954
-42,227
-28,022
-17,353
Cash
127,337
122,675
192,434
192,638
Basic Shares
35,024
33,325
29,935
29,935

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-156
-100
-300
-192
EBITDA
-108,274
-91,025
-47,386
-30,901
EBIT
-108,430
-91,125
-47,475
-30,933
Net Income
-109,357
-76,429
-46,090
-35,969
Net Change In Cash
0
0
0
0
Free Cash Flow
-94,431
-73,551
-42,403
-27,602
Cash
192,434
360,382
194,611
88,036
Basic Shares
27,606
22,315
11,640
4,321

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$1.58
2025-03-31
-$1.02
2024-12-31
-$0.98